These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 6889430)

  • 1. Inhibition of digoxin absorption but not of digitoxin during cytostatic drug therapy.
    Kuhlmann J
    Arzneimittelforschung; 1982; 32(6):698-704. PubMed ID: 6889430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cytostatic drugs on plasma level and renal excretion of beta-acetyldigoxin.
    Kuhlmann J; Zilly W; Wilke J
    Clin Pharmacol Ther; 1981 Oct; 30(4):518-27. PubMed ID: 7285486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytostatic drugs are without significant effect on digitoxin plasma level and renal excretion.
    Kuhlmann J; Wilke J; Rietbrock N
    Clin Pharmacol Ther; 1982 Nov; 32(5):646-51. PubMed ID: 6897028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of cardiac glycoside drug interactions.
    Hooymans PM; Merkus FW
    Clin Pharm; 1985; 4(4):404-13. PubMed ID: 2412751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digitalis therapy in renal failure with special regard to digitoxin.
    Vöhringer HF; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):175-84. PubMed ID: 7021432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Digitalization in cytostatic therapy].
    Kuhlman J
    Dtsch Med Wochenschr; 1981 Apr; 106(15):468-70. PubMed ID: 6163602
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of administration of activated charcoal and fibre on absorption, excretion and steady state blood levels of digoxin and digitoxin. Evidence for intestinal secretion of the glycosides.
    Reissell P; Manninen V
    Acta Med Scand Suppl; 1982; 668():88-90. PubMed ID: 6963097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication.
    Caldwell JH; Greenberger NJ
    J Clin Invest; 1971 Dec; 50(12):2626-37. PubMed ID: 5129314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of digoxin absorption by neomycin.
    Lindenbaum J; Maulitz RM; Butler VP
    Gastroenterology; 1976 Sep; 71(3):399-404. PubMed ID: 950089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of digoxin: some pitfalls and problems.
    Keller F; Rietbrock N
    Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):549-56. PubMed ID: 23358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of repeated plasma exchange on steady state kinetics of digoxin and digitoxin.
    Keller F; Hauff A; Schultze G; Offermann G; Reeck S; Molzahn M; Kreutz G; Vöhringer F
    Arzneimittelforschung; 1984; 34(1):83-6. PubMed ID: 6538425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of verapamil on pharmacokinetics and pharmacodynamics of digitoxin in patients.
    Kuhlmann J; Marcin S
    Am Heart J; 1985 Dec; 110(6):1245-50. PubMed ID: 4072882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interindividual differences in the pharmacokinetics of digitoxin and digoxin during long-term treatment.
    Haustein KO
    Eur J Clin Pharmacol; 1981 Jan; 19(1):45-51. PubMed ID: 7461023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cholestyramine in three patients with beta-acetyldigoxin, beta-methyldigoxin and digitoxin intoxication.
    Kuhlmann J
    Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):543-8. PubMed ID: 6511130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concentration of cardiac glycosides in the heart and brain (author's transl)].
    Flasch H; Heinz N
    Arzneimittelforschung; 1976; 26(6):1213-6. PubMed ID: 989419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rioprostil, a methyl-prostaglandin E1, on plasma level and renal excretion of beta-acetyldigoxin.
    Demol P; Wingender W; Kuhlmann J
    Scand J Gastroenterol Suppl; 1989; 164():68-71; discussion 71-2. PubMed ID: 2510284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of digoxin and digitoxin in patients undergoing hemodialysis.
    Finkelstein FO; Goffinet JA; Hendler ED; Lindenbaum J
    Am J Med; 1975 Apr; 58(4):525-31. PubMed ID: 1124790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriateness of the use of serum digoxin and digitoxin assays.
    Slaughter RL; Schneider PJ; Visconti JA
    Am J Hosp Pharm; 1978 Nov; 35(11):1376-9. PubMed ID: 707506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Color perception disorders in therapeutic glycoside serum concentrations].
    Duncker G; Horst H; Kolenda KD; Schenck F
    Fortschr Med; 1983 Nov; 101(43):1970-3. PubMed ID: 6654298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ketanserin on the kinetics of digoxin and digitoxin.
    Ochs HR; Verburg-Ochs B; Höller M; Greenblatt DJ
    J Cardiovasc Pharmacol; 1985; 7(1):205-7. PubMed ID: 2580144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.